VCAM1 and melanoma: It has revealed that DABK-treated mice with melanoma had a lower number of tumor cells in their lungs, a lower expression of vascular cell adhesion molecule 1 (VCAM-1), and an enhanced CD8+ T-cell infiltration in the metastatic area when compared to those that did not get therapy.